Newspaper Reports/Reviews of Afrezza

New inhaled drug to replace traditional insulin

Hindustan Times (Lucknow) 14 November 2015

New inhaled drug to replace traditional insulin

Technosphere inhaled insulin delivery appears safe

Published on consultant360.com on 16 September 2015

Technosphere inhaled insulin delivery appears safe

(Summary: pooled data indicate that diabetes treatment with insulin powder via the breath-powered Technosphere (Mannkind) inhalation device is safe. But long-term information is lacking.

As Dr. Anastassios G. Pittas told Reuters Health by email, “This newest type of inhaled insulin is an improved version of the prior type in terms of convenience to the patient and ease of use.”

However, he added, “Given lack of long-term information on safety, inhaled insulin should be reserved for patients who need insulin treatment but who are unable or unwilling to use injectable insulin.”

In a September 2 online paper in The Lancet Diabetes & Endocrinology, Dr. Pittas, of Tufts Medical Center, Boston, and colleagues noted that they came to this conclusion after examining outcomes in trials comparing mealtime Technosphere inhaled insulin with placebo, subcutaneous insulin, or oral antidiabetic drugs.)

 Inhaled insulin may eventually mean no more shots for some diabetics

Published on 16 June 2015 on nationalpost.com

Inhaled insulin may eventually mean no more shots for some diabetics

Weary of the needle jab, diabetics yearn for new form of insulin

Published on 15 June 2015 on washingtonpost.com

Weary of the needle jab, diabetics yearn for new form of insulin

MannKind’s inhaled insulin drug proves hard for diabetics to get

Published on 3 June 2015 on latimes.com

MannKind’s inhaled insulin drug proves hard for diabetics to get

Please follow and like us: